Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Assets Average (2020 - 2025)

Historic Assets Average for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to $288.2 million.

  • Pliant Therapeutics' Assets Average fell 3797.86% to $288.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $288.2 million, marking a year-over-year decrease of 3797.86%. This contributed to the annual value of $454.6 million for FY2024, which is 537.06% up from last year.
  • According to the latest figures from Q3 2025, Pliant Therapeutics' Assets Average is $288.2 million, which was down 3797.86% from $322.3 million recorded in Q2 2025.
  • In the past 5 years, Pliant Therapeutics' Assets Average registered a high of $586.4 million during Q2 2023, and its lowest value of $190.8 million during Q2 2022.
  • Its 5-year average for Assets Average is $373.7 million, with a median of $363.9 million in 2022.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 20729.72% in 2023, then plummeted by 3797.86% in 2025.
  • Quarter analysis of 5 years shows Pliant Therapeutics' Assets Average stood at $227.7 million in 2021, then skyrocketed by 59.84% to $363.9 million in 2022, then surged by 44.63% to $526.3 million in 2023, then decreased by 19.95% to $421.3 million in 2024, then tumbled by 31.59% to $288.2 million in 2025.
  • Its Assets Average was $288.2 million in Q3 2025, compared to $322.3 million in Q2 2025 and $370.9 million in Q1 2025.